GlycoNAVI Proteins

GlycoNAVI-Proteins is dataset of glycan and protein information. This is the content of GlycoNAVI.

Source Last Updated
GlycoNAVI Proteins September 04, 2024
Displaying entries 2351 - 2400 of 39437 in total
PDB ID UniProt ID Title Descriptor ▲
6MML Q00959 Diheteromeric NMDA receptor GluN1/GluN2A in the '2-Knuckle-Asymmetric' conformation, in complex with glycine and glutamate, in the presence of 1 micromolar zinc chloride, and at pH 7.4 Glutamate receptor ionotropic, NMDA 1, Glutamate receptor ionotropic, NMDA 2A
6MMX P35439 Triheteromeric NMDA receptor GluN1/GluN2A/GluN2A* in the 'Extended' conformation, in complex with glycine and glutamate, in the presence of 1 micromolar zinc chloride, and at pH 7.4 Glutamate receptor ionotropic, NMDA 1, Glutamate receptor ionotropic, NMDA 2A
6MMX Q00959 Triheteromeric NMDA receptor GluN1/GluN2A/GluN2A* in the 'Extended' conformation, in complex with glycine and glutamate, in the presence of 1 micromolar zinc chloride, and at pH 7.4 Glutamate receptor ionotropic, NMDA 1, Glutamate receptor ionotropic, NMDA 2A
6MMH P35439 Diheteromeric NMDA receptor GluN1/GluN2A in the 'Extended-2' conformation, in complex with glycine and glutamate, in the presence of 1 millimolar zinc chloride, and at pH 7.4 Glutamate receptor ionotropic, NMDA 1, Glutamate receptor ionotropic, NMDA 2A
6MMH Q00959 Diheteromeric NMDA receptor GluN1/GluN2A in the 'Extended-2' conformation, in complex with glycine and glutamate, in the presence of 1 millimolar zinc chloride, and at pH 7.4 Glutamate receptor ionotropic, NMDA 1, Glutamate receptor ionotropic, NMDA 2A
6MMP P35439 Diheteromeric NMDA receptor GluN1/GluN2A in the '2-Knuckle-Symmetric' conformation, in complex with glycine and glutamate, in the presence of 0.1 millimolar EDTA, and at pH 8.0 Glutamate receptor ionotropic, NMDA 1, Glutamate receptor ionotropic, NMDA 2A
6MMP Q00959 Diheteromeric NMDA receptor GluN1/GluN2A in the '2-Knuckle-Symmetric' conformation, in complex with glycine and glutamate, in the presence of 0.1 millimolar EDTA, and at pH 8.0 Glutamate receptor ionotropic, NMDA 1, Glutamate receptor ionotropic, NMDA 2A
6MMR P35439 Diheteromeric NMDA receptor GluN1/GluN2A in the '2-Knuckle-Symmetric' conformation, in complex with glycine and glutamate, in the presence of 1 millimolar zinc chloride, 3 millimolar EDTA, and at pH 7.4 Glutamate receptor ionotropic, NMDA 1, Glutamate receptor ionotropic, NMDA 2A
6MMR Q00959 Diheteromeric NMDA receptor GluN1/GluN2A in the '2-Knuckle-Symmetric' conformation, in complex with glycine and glutamate, in the presence of 1 millimolar zinc chloride, 3 millimolar EDTA, and at pH 7.4 Glutamate receptor ionotropic, NMDA 1, Glutamate receptor ionotropic, NMDA 2A
6MMN P35439 Diheteromeric NMDA receptor GluN1/GluN2A in the '2-Knuckle-Symmetric' conformation, in complex with glycine and glutamate, in the presence of 1 micromolar zinc chloride, and at pH 8.0 Glutamate receptor ionotropic, NMDA 1, Glutamate receptor ionotropic, NMDA 2A
6MMN Q00959 Diheteromeric NMDA receptor GluN1/GluN2A in the '2-Knuckle-Symmetric' conformation, in complex with glycine and glutamate, in the presence of 1 micromolar zinc chloride, and at pH 8.0 Glutamate receptor ionotropic, NMDA 1, Glutamate receptor ionotropic, NMDA 2A
6MMV P35439 Triheteromeric NMDA receptor GluN1/GluN2A/GluN2A* Extracellular Domain in the '2-Knuckle-Asymmetric' conformation, in complex with glycine and glutamate, in the presence of 1 micromolar zinc chloride, and at pH 7.4 Glutamate receptor ionotropic, NMDA 1, Glutamate receptor ionotropic, NMDA 2A
6MMV Q00959 Triheteromeric NMDA receptor GluN1/GluN2A/GluN2A* Extracellular Domain in the '2-Knuckle-Asymmetric' conformation, in complex with glycine and glutamate, in the presence of 1 micromolar zinc chloride, and at pH 7.4 Glutamate receptor ionotropic, NMDA 1, Glutamate receptor ionotropic, NMDA 2A
6WHU P35439 GluN1b-GluN2B NMDA receptor in complex with SDZ 220-040 and L689,560, class 1 Glutamate receptor ionotropic, NMDA 1, Glutamate receptor ionotropic, NMDA 2B
6WHU Q00960 GluN1b-GluN2B NMDA receptor in complex with SDZ 220-040 and L689,560, class 1 Glutamate receptor ionotropic, NMDA 1, Glutamate receptor ionotropic, NMDA 2B
6WHV P35439 GluN1b-GluN2B NMDA receptor in complex with SDZ 220-040 and L689,560, class 2 Glutamate receptor ionotropic, NMDA 1, Glutamate receptor ionotropic, NMDA 2B
6WHV Q00960 GluN1b-GluN2B NMDA receptor in complex with SDZ 220-040 and L689,560, class 2 Glutamate receptor ionotropic, NMDA 1, Glutamate receptor ionotropic, NMDA 2B
6WHR P35439 GluN1b-GluN2B NMDA receptor in non-active 2 conformation at 4 angstrom resolution Glutamate receptor ionotropic, NMDA 1, Glutamate receptor ionotropic, NMDA 2B
6WHR Q00960 GluN1b-GluN2B NMDA receptor in non-active 2 conformation at 4 angstrom resolution Glutamate receptor ionotropic, NMDA 1, Glutamate receptor ionotropic, NMDA 2B
6CNA P35439 GluN1-GluN2B NMDA receptors with exon 5 Glutamate receptor ionotropic, NMDA 1, Glutamate receptor ionotropic, NMDA 2B
6CNA Q00960 GluN1-GluN2B NMDA receptors with exon 5 Glutamate receptor ionotropic, NMDA 1, Glutamate receptor ionotropic, NMDA 2B
6WHT P35439 GluN1b-GluN2B NMDA receptor in active conformation at 4.4 angstrom resolution Glutamate receptor ionotropic, NMDA 1, Glutamate receptor ionotropic, NMDA 2B
6WHT Q00960 GluN1b-GluN2B NMDA receptor in active conformation at 4.4 angstrom resolution Glutamate receptor ionotropic, NMDA 1, Glutamate receptor ionotropic, NMDA 2B
6WI0 P35439 GluN1b-GluN2B NMDA receptor in complex with GluN1 antagonist L689,560, class 2 Glutamate receptor ionotropic, NMDA 1, Glutamate receptor ionotropic, NMDA 2B
6WI0 Q00960 GluN1b-GluN2B NMDA receptor in complex with GluN1 antagonist L689,560, class 2 Glutamate receptor ionotropic, NMDA 1, Glutamate receptor ionotropic, NMDA 2B
6WHS P35439 GluN1b-GluN2B NMDA receptor in non-active 1 conformation at 3.95 angstrom resolution Glutamate receptor ionotropic, NMDA 1, Glutamate receptor ionotropic, NMDA 2B
6WHS Q00960 GluN1b-GluN2B NMDA receptor in non-active 1 conformation at 3.95 angstrom resolution Glutamate receptor ionotropic, NMDA 1, Glutamate receptor ionotropic, NMDA 2B
6UTO A0A0U4BD45 Native E. coli Glyceraldehyde 3-phosphate dehydrogenase Glyceraldehyde-3-phosphate dehydrogenase (E.C.1.2.1.-)
6UTN A0A0U4BD45 Native E. coli Glyceraldehyde 3-phosphate dehydrogenase Glyceraldehyde-3-phosphate dehydrogenase (E.C.1.2.1.-)
6UBS O93430 Full length Glycine receptor reconstituted in lipid nanodisc in Apo/Resting conformation Glycine receptor subunit alphaZ1
6UBT O93430 Full length Glycine receptor reconstituted in lipid nanodisc in Gly-bound desensitized conformation Glycine receptor subunit alphaZ1
6UAZ A0A179UGT5 Crystal structure of a GH128 (subgroup III) curdlan-specific exo-beta-1,3-glucanase from Blastomyces gilchristii (BgGH128_III) in complex with glucose Glyco_hydro_cc domain-containing protein
3CEH P06737 Human liver glycogen phosphorylase (tense state) in complex with the allosteric inhibitor AVE5688 Glycogen phosphorylase (E.C.2.4.1.1)
3CEM P06737 Human glycogen phosphorylase (tense state) in complex with the allosteric inhibitor AVE9423 Glycogen phosphorylase (E.C.2.4.1.1)
2ATI P06737 Glycogen Phosphorylase Inhibitors Glycogen phosphorylase, liver form (E.C.2.4.1.1)
1L7X P06737 Human liver glycogen phosphorylase b complexed with caffeine, N-acetyl-beta-D-glucopyranosylamine, and CP-403,700 Glycogen phosphorylase, liver form (E.C.2.4.1.1.)
1L5Q P06737 Human liver glycogen phosphorylase a complexed with caffeine, N-Acetyl-beta-D-glucopyranosylamine, and CP-403700 Glycogen phosphorylase, liver form (E.C.2.4.4.1)
1L5S P06737 Human liver glycogen phosphorylase complexed with uric acid, N-Acetyl-beta-D-glucopyranosylamine, and CP-403,700 Glycogen phosphorylase, liver form (E.C.2.4.4.1)
1XC7 P00489 Binding of beta-D-glucopyranosyl bismethoxyphosphoramidate to glycogen phosphorylase b: Kinetic and crystallographic studies Glycogen phosphorylase, muscle form (E.C.2.4.1.1)
1XL0 P00489 Kinetic and crystallographic studies on 2-(beta-D-glucopyranosyl)-5-methyl-1,3,4-oxadiazole,-benzothiazole, and-benzimidazole, inhibitors of muscle glycogen phosphorylase b. Evidence for a new binding site. Glycogen phosphorylase, muscle form (E.C.2.4.1.1)
1XL1 P00489 Kinetic and crystallographic studies on 2-(beta-D-glucopyranosyl)-5-methyl-1,3,4-oxadiazole,-benzothiazole, and-benzimidazole, inhibitors of muscle glycogen phosphorylase b. Evidence for a new binding site. Glycogen phosphorylase, muscle form (E.C.2.4.1.1)
3SYM P00489 Glycogen Phosphorylase b in complex with 3 -C-(hydroxymethyl)-beta-D-glucopyranonucleoside of 5-fluorouracil Glycogen phosphorylase, muscle form (E.C.2.4.1.1)
3SYR P00489 Glycogen phosphorylase b in complex with beta-D-glucopyranonucleoside 5-fluorouracil Glycogen phosphorylase, muscle form (E.C.2.4.1.1)
5LRC P00489 Crystal structure of Glycogen Phosphorylase in complex with KS114 Glycogen phosphorylase, muscle form (E.C.2.4.1.1)
5OX0 P00489 Glycogen Phosphorylase in complex with CK898 Glycogen phosphorylase, muscle form (E.C.2.4.1.1)
5OX3 P00489 Glycogen Phosphorylase in complex with SzB102v Glycogen phosphorylase, muscle form (E.C.2.4.1.1)
1S4N P27809 Crystal structure of yeast alpha1,2-mannosyltransferase Kre2p/Mnt1p Glycolipid 2-alpha-mannosyltransferase (E.C.2.4.1.131)
6TMR P0C572 Mokola virus glycoprotein, monomeric post-fusion conformation Glycoprotein
6VY2 A0A0A7I3C6 Cryo-EM structure of M1214_N1 Fab in complex with CH505 TF chimeric SOSIP.664 Env trimer Glycoprotein 120, Glycoprotein 41, M1214 N1 Fab heavy chain, M1214 N1 Fab light chain
6VY2 Q2N0S5 Cryo-EM structure of M1214_N1 Fab in complex with CH505 TF chimeric SOSIP.664 Env trimer Glycoprotein 120, Glycoprotein 41, M1214 N1 Fab heavy chain, M1214 N1 Fab light chain

About Release Notes Help Feedback

Click here to visit the beta site.


International Collaboration

GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.

Acknowledgements

Supported by JST NBDC Grant Number JPMJND2204

Partly supported by NIH Common Fund Grant #1U01GM125267-01


Logo License Policies Site Map

Contact: support@glycosmos.org

This work is licensed under Creative Commons Attribution 4.0 International


GlyCosmos Portal v4.0.0

Last updated: August 19, 2024